background

Publications

Publications

Hypovolemic Shock

Gulati, A., Goyal, A. O., Lavhale, M. S., Gulati, S., and M., S. (2016) Human Pharmacokinetics of Centhaquin Citrate, a Novel Resuscitative Agent. Circulation, 134:A16607

Alzheimer's Disease

Briyal, S., C. Nguyen, M. Leonard, and A. Gulati. Stimulation of endothelin B receptors by IRL-1620 decreases the progression of Alzheimer’s disease. Neuroscience 301 (2015): 1-11

Post Operative Pain

Leonard, M. G., Jung, S., Andurkar, S. V., and Gulati, A. (2014) Centhaquin Produces Dose-dependent Antinociception in a Rat Model of Post-operative Pain. Clin Pharmacol in Drug Develop 3, 52-53

Ischemic Stroke

Leonard, M. G., and Gulati, A. (2013) Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats. Brain Res 1528, 28-41

Cardiac Arrest

Papalexopoulou, K., Chalkias, A., Pliatsika, P., Papalois, A., Papapanagiotou, P., Papadopoulos, G., Arnaoutoglou, E., Petrou, A., Gulati, A., and Xanthos, T. (2017) Centhaquin Effects in a Swine Model of Ventricular Fibrillation: Centhaquin and Cardiac Arrest. Heart Lung Circ 26, 856-863

Spinal Cord Injury

Leonard, M. G., Prazad, P., Puppala, B., and Gulati, A. (2015) Selective Endothelin-B Receptor Stimulation Increases Vascular Endothelial Growth Factor in the Rat Brain during Postnatal Development. Drug Res (Stuttg) 65, 607-613

Diabetic Ketoacidosis

Gulati, A., Lavhale, M., and Havalad, S. (2013) BQ123, An ETA receptor antagonist, in the treatment of Diabetic Ketoacidosis. Crit Care Med 41

Opioid Tolerance

Bhalla, S., Pais, G., Tapia, M., and Gulati, A. (2015) Endothelin ETA receptor antagonist reverses naloxone-precipitated opioid withdrawal in mice. Can J Physiol Pharmacol 93, 935-944